id,term,root,synonym,category
CUS001,NCT05799287,NCT05799287,18C021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18 C 021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18-C-021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18-C021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18C-021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18 C021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18C 021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18 C-021,Clinical Trial
CUS001,NCT05799287,NCT05799287,18-C 021,Clinical Trial
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,TRF-Budesonide,T`rea`tment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,TRF Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,TRFBudesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Targeted Release Formulation Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Targeted Release Formulation-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site-Specific Formulation Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site Specific Formulation Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site-Specific Formulation-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site Specific Formulation-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Targeted-Delivery Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Targeted Delivery Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Targeted-Delivery-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Targeted Delivery-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site-Specific Delivery Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site Specific Delivery Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site-Specific Delivery-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Site Specific Delivery-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Smart Drug Delivery Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Smart-Drug Delivery Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Smart-Drug Delivery-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Smart Drug Delivery-Budesonide,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Nefecon,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,Nefegan,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,PL-56,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,PL56,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,PL 56,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,VR-205,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,VR205,Treatment
CUS002,targeted-release formulation budesonide,Targeted-Release Formulation Budesonide,VR 205,Treatment
CUS003,Methylprednisone,Methylprednisone,Methyl prednisone,Treatment
CUS003,Methylprednisone,Methylprednisone,Methyl-prednisone,Treatment
CUS004,Immune Complex,Immune Complex,Immunocomplex,Treatment Class
CUS004,Immune Complex,Immune Complex,Immunological Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Immunological-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Immuno-complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Immuno complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Immune-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Immunocomplexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Immunological Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Immunological-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Immuno-complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Immuno complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Immune-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Immuno Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Immuno Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Immuno-Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Immuno-Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Immune Complexes,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen-Antibody Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antigen Antibody Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag-Ab Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ag Ab Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody-Antigen Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Antibody Antigen Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab-Ag Immune Complex,Treatment Class
CUS004,Immune Complex,Immune Complex,Ab Ag Immune Complex,Treatment Class
CUS005,KDIGO,KDIGO,Kidney Disease: Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease-Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease - Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease : Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease:Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease | Improving Global Outcomes,Other
CUS005,KDIGO,KDIGO,Kidney Disease: Improving Global Outcome,Other
CUS005,KDIGO,KDIGO,Kidney Disease Improving Global Outcome,Other
CUS005,KDIGO,KDIGO,Kidney Disease-Improving Global Outcome,Other
CUS005,KDIGO,KDIGO,Kidney Disease - Improving Global Outcome,Other
CUS005,KDIGO,KDIGO,Kidney Disease : Improving Global Outcome,Other
CUS005,KDIGO,KDIGO,Kidney Disease:Improving Global Outcome,Other
CUS005,KDIGO,KDIGO,Kidney Disease | Improving Global Outcome,Other
CUS006,Disease modification,Disease Modification,Therapeutic Intervention,Other
CUS006,Disease modification,Disease Modification,Disease Course Alteration,Other
CUS006,Disease modification,Disease Modification,Disease Course Modification,Other
CUS006,Disease modification,Disease Modification,Disease Progression Modification,Other
CUS006,Disease modification,Disease Modification,Disease Intervention,Other
CUS006,Disease modification,Disease Modification,Therapeutic Modification,Other
CUS006,Disease modification,Disease Modification,Disease-Modifying Treatment,Other
CUS006,Disease modification,Disease Modification,Disease-Modifying Treatments,Other
CUS006,Disease modification,Disease Modification,Disease Modifying Treatment,Other
CUS006,Disease modification,Disease Modification,Disease Modifying Treatments,Other
CUS006,Disease modification,Disease Modification,Disease-Modifying Therapy,Other
CUS006,Disease modification,Disease Modification,Disease-Modifying Therapies,Other
CUS006,Disease modification,Disease Modification,Disease Modifying Therapy,Other
CUS006,Disease modification,Disease Modification,Disease Modifying Therapies,Other
CUS006,Disease modification,Disease Modification,Disease Process Modulation,Other
CUS006,Disease modification,Disease Modification,Disease Progression Alteration,Other
CUS007,Remission,Remission,Remission,Other
CUS007,Remission,Remission,Complete Remission,Other
CUS007,Remission,Remission,Partial Remission,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA-IgG Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Immune Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA-IgG Immuno Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Immuno Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Immuno Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA-IgG Immuno Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA-IgG Immunocomplex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Immunocomplex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Immunocomplexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA-IgG Immunocomplexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgA/IgG Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG-IgA Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Immune Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG-IgA Immuno Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Immuno Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Immuno Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG-IgA Immuno Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG-IgA Immunocomplex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Immunocomplex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Immunocomplexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG-IgA Immunocomplexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG/IgA Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,IgG-IgA Immune Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,Immunoglobulin A-G Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,Immunoglobulin A-G Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,Immunoglobulin G-A Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,Immunoglobulin G-A Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinA-ImmunoglobulinG Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinA/ImmunoglobulinG Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinA/ImmunoglobulinG Immune Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinA/ImmunoglobulinG Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinA/ImmunoglobulinG Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinG-ImmunoglobulinA Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinG/ImmunoglobulinA Immune Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinG/ImmunoglobulinA Immune Complexes,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinG/ImmunoglobulinA Complex,Other
CUS008,IgA-IgG immune complexes,IgA-IgG Immune Complexes,ImmunoglobulinG/ImmunoglobulinA Complexes,Other
CUS009,Subgroup ,Subgroup ,Cohort,Other
CUS009,Subgroup ,Subgroup ,Subset,Other
CUS009,Subgroup ,Subgroup ,Sub set,Other
CUS009,Subgroup ,Subgroup ,Sub-set,Other
CUS009,Subgroup ,Subgroup ,Sub group ,Other
CUS009,Subgroup ,Subgroup ,Sub population,Other
CUS009,Subgroup ,Subgroup ,Sub classification,Other
CUS009,Subgroup ,Subgroup ,Sub division,Other
CUS009,Subgroup ,Subgroup ,Subpopulation,Other
CUS009,Subgroup ,Subgroup ,Demographic,Other
CUS009,Subgroup ,Subgroup ,Subclassification,Other
CUS009,Subgroup ,Subgroup ,Subdivision,Other
CUS009,Subgroup ,Subgroup ,Sub-division,Other
CUS009,Subgroup ,Subgroup ,Sub-group ,Other
CUS009,Subgroup ,Subgroup ,Sub-classification,Other
CUS009,Subgroup ,Subgroup ,Sub-population,Other
CUS010,immunosuppression,Immunosuppression,Immunosenescence,Other
CUS010,immunosuppression,Immunosuppression,Immuno-Senescence,Other
CUS010,immunosuppression,Immunosuppression,Immuno Senescence,Other
CUS010,immunosuppression,Immunosuppression,Immunocompromised,Other
CUS010,immunosuppression,Immunosuppression,Immuno Compromised,Other
CUS010,immunosuppression,Immunosuppression,Immunocompromise,Other
CUS010,immunosuppression,Immunosuppression,Immuno-Compromised,Other
CUS010,immunosuppression,Immunosuppression,Immuno Compromise,Other
CUS010,immunosuppression,Immunosuppression,Immuno-Compromise,Other
CUS010,immunosuppression,Immunosuppression,Immune Suppression,Other
CUS010,immunosuppression,Immunosuppression,Immunological Suppression,Other
CUS010,immunosuppression,Immunosuppression,Suppressed Immunity,Other
CUS010,immunosuppression,Immunosuppression,Immunological-Suppression,Other
CUS010,immunosuppression,Immunosuppression,Immune-Suppression,Other
CUS010,immunosuppression,Immunosuppression,Immuno suppression,Other
CUS010,immunosuppression,Immunosuppression,Immuno-suppression,Other
CUS010,immunosuppression,Immunosuppression,Immunosuppressed,Other
CUS010,immunosuppression,Immunosuppression,Immuno suppressed,Other
CUS010,immunosuppression,Immunosuppression,Immuno-suppressed,Other
CUS010,immunosuppression,Immunosuppression,Immunoinhibition,Other
CUS010,immunosuppression,Immunosuppression,Immuno-Inhibition,Other
CUS010,immunosuppression,Immunosuppression,Immuno Inhibition,Other
CUS011,Standard of care,Standard of Care,Standard Medical Care,Other 
CUS011,Standard of care,Standard of Care,Standard-Medical-Care,Other 
CUS011,Standard of care,Standard of Care,Standard  Medical-Care,Other 
CUS011,Standard of care,Standard of Care,Standard-Medical Care,Other 
CUS011,Standard of care,Standard of Care,Standard Therapy,Other 
CUS011,Standard of care,Standard of Care,Standard-Therapy,Other 
CUS011,Standard of care,Standard of Care,Standard Treatment,Other 
CUS011,Standard of care,Standard of Care,Standard Treatments,Other 
CUS012,Biomarkers,Biomarkers,Biomarker,Other 
CUS012,Biomarkers,Biomarkers,Biological Markers,Other 
CUS012,Biomarkers,Biomarkers,Biologic Markers,Other 
CUS012,Biomarkers,Biomarkers,Biological Marker,Other 
CUS012,Biomarkers,Biomarkers,Biologic Marker,Other 
CUS012,Biomarkers,Biomarkers,Biological-Markers,Other 
CUS012,Biomarkers,Biomarkers,Biologic-Markers,Other 
CUS012,Biomarkers,Biomarkers,Biological-Marker,Other 
CUS012,Biomarkers,Biomarkers,Biologic-Marker,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical Trial Endpoint,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Trial Endpoints,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Trial Endpoint,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical Endpoint,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical Endpoints,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical Study Endpoint,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical Study Endpoints,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical-Study Endpoint,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical-Study Endpoints,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical-Trial Endpoints,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Clinical-Trial Endpoint,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Endpoint ,Other 
CUS013,Clinical Trial Endpoints,Clinical Trial Endpoints,Endpoints,Other 
CUS014,treatment options,Treatment Options,Treatment Option,Other 
CUS014,treatment options,Treatment Options,Treatment Choices,Other 
CUS014,treatment options,Treatment Options,Treatment Choice,Other 
CUS014,treatment options,Treatment Options,Treatment Alternatives,Other 
CUS014,treatment options,Treatment Options,Treatment Alternative,Other 
CUS014,treatment options,Treatment Options,Intervention Options,Other 
CUS014,treatment options,Treatment Options,Intervention Option,Other 
CUS014,treatment options,Treatment Options,Intervention Choices,Other 
CUS014,treatment options,Treatment Options,Intervention Choice,Other 
CUS014,treatment options,Treatment Options,Intervention Alternative,Other 
CUS014,treatment options,Treatment Options,Intervention Alternatives,Other 
CUS015,MEST-C,MEST-C,MEST-C Score,Other 
CUS015,MEST-C,MEST-C,MEST-C Scores,Other 
CUS015,MEST-C,MEST-C,MEST-C Criteria,Other 
CUS015,MEST-C,MEST-C,MEST C,Other 
CUS016,pathogenic Mechanisms,Pathogenic Mechanisms,Pathogenic Mechanism,Other 
CUS016,pathogenic Mechanisms,Pathogenic Mechanisms,Pathogenic Processes,Other 
CUS016,pathogenic Mechanisms,Pathogenic Mechanisms,Pathogenic Process,Other 
CUS016,pathogenic Mechanisms,Pathogenic Mechanisms,Mechanisms of Pathogenesis,Other 
CUS016,pathogenic Mechanisms,Pathogenic Mechanisms,Mechanism of Pathogenesis,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immunosuppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immune Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immune-Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immune Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immune-Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immuno Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immuno-Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immuno Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immuno-Suppression,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immunosuppressed,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immunosuppressed,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immuno Suppressed,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non-Immuno-Suppressed,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immuno Suppressed,Other 
CUS017,non-immunosuppression,Non-Immunosuppression,Non Immuno-Suppressed,Other 
CUS018,Standard of care,Standard of Care,Standard-of-Care,Other 
CUS018,Standard of care,Standard of Care,Standard Medical Care,Other 
CUS018,Standard of care,Standard of Care,Standard-Medical-Care,Other 
CUS018,Standard of care,Standard of Care,Standard  Medical-Care,Other 
CUS018,Standard of care,Standard of Care,Standard-Medical Care,Other 
CUS018,Standard of care,Standard of Care,Standard Therapy,Other 
CUS018,Standard of care,Standard of Care,Standard-Therapy,Other 
CUS018,Standard of care,Standard of Care,Standard Treatment,Other 
CUS018,Standard of care,Standard of Care,Standard Treatments,Other 
CUS019,UACR,uACR,Urine Albumin-Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urine Albumin Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urine Albumin-To-Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urine Albumin To Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urinary Albumin-Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urinary Albumin Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urinary Albumin-To-Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urinary Albumin To Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urinary Albumin:Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urine Albumin:Creatinine Ratio,Endpoints
CUS019,UACR,uACR,Urinary ACR,Endpoints
CUS019,UACR,uACR,Urine ACR,Endpoints
CUS019,UACR,uACR,Urine A/C Ratio,Endpoints
CUS019,UACR,uACR,Urinary A/C Ratio,Endpoints
CUS019,UACR,uACR,Urinary-ACR,Endpoints
CUS019,UACR,uACR,Urine-ACR,Endpoints
CUS020,UPCR,UPCR,Urine Protein Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urine Protein-Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary Protein:Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urine Protein:Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary Protein-Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urine Protein To Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urine Protein-To-Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary Protein To Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary Protein-To-Creatinine Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary PCR,Endpoints
CUS020,UPCR,UPCR,Urine PCR,Endpoints
CUS020,UPCR,UPCR,Urine P/C Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary P/C Ratio,Endpoints
CUS020,UPCR,UPCR,Urinary-PCR,Endpoints
CUS020,UPCR,UPCR,Urine-PCR,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,Estimated GFR,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,Estimate GFR,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,Glomerular Filtration Rate Estimate,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,Glomerular Filtration Rate Estimated,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,estimate glomerular filtration rate,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,estimate glomerular filtration rates,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,estimated glomerular filtration rates,Endpoints
CUS021,eGFR,Estimated Glomerular Filtration Rate,Estimated Glomerular Filtration Rate,Endpoints
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT2 Blockade,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT-2 Blockade,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT2 Suppression,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT-2 Suppression,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT2 Antagonist Activity,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT-2 Antagonist Activity,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium-Glucose Cotransporter 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium-Glucose Cotransporter-2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium Glucose Cotransporter-2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium Glucose Cotransporter2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium Glucose Cotransporter 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium-Glucose Cotransporter2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium -Glucose Cotransporter 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium -Glucose Cotransporter -2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium -Glucose Cotransporter-2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium- Glucose Cotransporter- 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium - Glucose Cotransporter - 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium-Glucose Transporter-2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium Glucose Transporter-2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium Glucose Transporter2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium Glucose Transporter 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium-Glucose Transporter2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium -Glucose Transporter 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium -Glucose Transporter -2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium -Glucose Transporter-2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium- Glucose Transporter- 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,Sodium - Glucose Transporter - 2 Inhibition,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT2 Receptor Blockade,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT-2 Receptor Blockade,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT 2 Receptor Blockade,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT2 Inhibitor,Treatment Class
CUS022,SGLT2 Inhibition,SGLT2 Inhibition,SGLT2 Inhibitors,Treatment Class
CUS023,Gd-IgA,Gd-IgA,Gd IgA,Other
CUS023,Gd-IgA,Gd-IgA,GdIgA,Other
CUS023,Gd-IgA,Gd-IgA,Galactose-Deficient IgA,Other
CUS023,Gd-IgA,Gd-IgA,Galactose Deficient IgA,Other
CUS023,Gd-IgA,Gd-IgA,Gd Ig A,Other
CUS023,Gd-IgA,Gd-IgA,GdIg A,Other
CUS023,Gd-IgA,Gd-IgA,Gd-Ig A,Other
CUS023,Gd-IgA,Gd-IgA,Galactose-Deficient-IgA,Other
CUS023,Gd-IgA,Gd-IgA,Galactose Deficient-IgA,Other
CUS023,Gd-IgA,Gd-IgA,Gd-Immunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,Galactose-Deficient Immunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,Gd Immunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,Galactose Deficient Immunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,Galactose-Deficient-Immunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,Galactose Deficient-Immunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,GdImmunoglobulin A,Other
CUS023,Gd-IgA,Gd-IgA,Galactose Deficient ImmunoglobulinA,Other
CUS023,Gd-IgA,Gd-IgA,Galactose-Deficient-ImmunoglobulinA,Other
CUS023,Gd-IgA,Gd-IgA,Galactose Deficient-ImmunoglobulinA,Other
CUS023,Gd-IgA,Gd-IgA,Gd ImmunoglobulinA,Other
CUS023,Gd-IgA,Gd-IgA,Gd-ImmunoglobulinA,Other
CUS023,Gd-IgA,Gd-IgA,GdImmunoglobulinA,Other
CUS023,Gd-IgA,Gd-IgA,Galactose-Deficient ImmunoglobulinA,Other
CUS024,IgA1,IgA1,IgA 1,Other
CUS024,IgA1,IgA1,Immunoglobulin A 1,Other
CUS024,IgA1,IgA1,Immunoglobulin-A 1,Other
CUS024,IgA1,IgA1,ImmunoglobulinA 1,Other
CUS024,IgA1,IgA1,IgA-1,Other
CUS024,IgA1,IgA1,Immunoglobulin A-1,Other
CUS024,IgA1,IgA1,Immunoglobulin-A-1,Other
CUS024,IgA1,IgA1,ImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd IgA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdIgA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient IgA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient IgA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd Ig A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdIg A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd-Ig A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient-IgA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient-IgA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd-Immunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient Immunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd Immunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient Immunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient-Immunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient-Immunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdImmunoglobulin A 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient ImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient-ImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient-ImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd ImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd-ImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient ImmunoglobulinA 1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd IgA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdIgA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient IgA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient IgA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd Ig A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdIg A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd-Ig A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient-IgA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient-IgA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd-Immunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient Immunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd Immunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient Immunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient-Immunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient-Immunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdImmunoglobulin A-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient ImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient-ImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose Deficient-ImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd ImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Gd-ImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,GdImmunoglobulinA-1,Other
CUS025,Gd-IgA1,Gd-IgA1,Galactose-Deficient ImmunoglobulinA-1,Other
CUS026,Galactose deficient ,Galactose deficient ,Galactose deficient ,Other
CUS026,Galactose deficient ,Galactose deficient ,Galactose-deficient ,Other
CUS027,B cell depletion,B cell depletion,B-Cell Depletion,Other
CUS027,B cell depletion,B cell depletion,Depletion of B Cell,Other
CUS027,B cell depletion,B cell depletion,Depletion of B-Cell,Other
CUS027,B cell depletion,B cell depletion,B Cell Reduction,Other
CUS027,B cell depletion,B cell depletion,B-Cell Reduction,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Depletion,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Depletion,Other
CUS027,B cell depletion,B cell depletion,B Cell Suppression,Other
CUS027,B cell depletion,B cell depletion,B-Cell Suppression,Other
CUS027,B cell depletion,B cell depletion,B Cell Depleted,Other
CUS027,B cell depletion,B cell depletion,B-Cell Depleted,Other
CUS027,B cell depletion,B cell depletion,B Cell Depleting,Other
CUS027,B cell depletion,B cell depletion,B-Cell Depleting,Other
CUS027,B cell depletion,B cell depletion,B Cell Reduced,Other
CUS027,B cell depletion,B cell depletion,B-Cell Reduced,Other
CUS027,B cell depletion,B cell depletion,B Cell Reducing,Other
CUS027,B cell depletion,B cell depletion,B-Cell Reducing,Other
CUS027,B cell depletion,B cell depletion,B Cell Suppressed,Other
CUS027,B cell depletion,B cell depletion,B-Cell Suppressed,Other
CUS027,B cell depletion,B cell depletion,B Cell Suppressing,Other
CUS027,B cell depletion,B cell depletion,B-Cell Suppressing,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Depleted,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Depleted,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Depleting,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Depleting,Other
CUS027,B cell depletion,B cell depletion,Depletion of B-Lymphocyte,Other
CUS027,B cell depletion,B cell depletion,Suppression of B-Cell,Other
CUS027,B cell depletion,B cell depletion,Suppression of B Cell,Other
CUS027,B cell depletion,B cell depletion,Reduction of B Cell,Other
CUS027,B cell depletion,B cell depletion,Reduction of B-Cell,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Reduction,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Reduction,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Reduced,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Reducing,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Reducing,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Suppression,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Suppression,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Suppressed,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Suppressed,Other
CUS027,B cell depletion,B cell depletion,B Lymphocyte Suppressing,Other
CUS027,B cell depletion,B cell depletion,B-Lymphocyte Suppressing,Other
CUS027,B cell depletion,B cell depletion,BCell Depletion,Other
CUS027,B cell depletion,B cell depletion,Depletion of BCell,Other
CUS027,B cell depletion,B cell depletion,BCell Reduction,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Depletion,Other
CUS027,B cell depletion,B cell depletion,BCell Suppression,Other
CUS027,B cell depletion,B cell depletion,BCell Depleted,Other
CUS027,B cell depletion,B cell depletion,BCell Depleting,Other
CUS027,B cell depletion,B cell depletion,BCell Reduced,Other
CUS027,B cell depletion,B cell depletion,BCell Reducing,Other
CUS027,B cell depletion,B cell depletion,BCell Suppressed,Other
CUS027,B cell depletion,B cell depletion,BCell Suppressing,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Depleted,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Depleting,Other
CUS027,B cell depletion,B cell depletion,Depletion of BLymphocyte,Other
CUS027,B cell depletion,B cell depletion,Suppression of BCell,Other
CUS027,B cell depletion,B cell depletion,Reduction of BCell,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Reduction,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Reduced,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Reducing,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Suppression,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Suppressed,Other
CUS027,B cell depletion,B cell depletion,BLymphocyte Suppressing,Other
CUS028,B cell activation ,B cell activation ,B Cell Activated,Other
CUS028,B cell activation ,B cell activation ,B Cell Activating,Other
CUS028,B cell activation ,B cell activation ,B-Cell Activated,Other
CUS028,B cell activation ,B cell activation ,B-Cell Activating,Other
CUS028,B cell activation ,B cell activation ,Activation of B Cell,Other
CUS028,B cell activation ,B cell activation ,Activation of B-Cell,Other
CUS028,B cell activation ,B cell activation ,B Lymphocyte Activation,Other
CUS028,B cell activation ,B cell activation ,B-Lymphocyte Activation,Other
CUS028,B cell activation ,B cell activation ,B-Lymphocyte Activated,Other
CUS028,B cell activation ,B cell activation ,B-Lymphocyte Activating,Other
CUS028,B cell activation ,B cell activation ,B Cell Stimulation,Other
CUS028,B cell activation ,B cell activation ,B-Cell Stimulation,Other
CUS028,B cell activation ,B cell activation ,B Cell Stimulated,Other
CUS028,B cell activation ,B cell activation ,B-Cell Stimulated,Other
CUS028,B cell activation ,B cell activation ,B Cell Stimulating,Other
CUS028,B cell activation ,B cell activation ,B-Cell Stimulating,Other
CUS028,B cell activation ,B cell activation ,Stimulation of B Cell,Other
CUS028,B cell activation ,B cell activation ,Stimulation of B-Cell,Other
CUS028,B cell activation ,B cell activation ,B Cell Triggering,Other
CUS028,B cell activation ,B cell activation ,B-Cell Triggering,Other
CUS028,B cell activation ,B cell activation ,B Cell Triggered,Other
CUS028,B cell activation ,B cell activation ,B-Cell Triggered,Other
CUS028,B cell activation ,B cell activation ,Trigerring of B Cell,Other
CUS028,B cell activation ,B cell activation ,Trigerring of B-Cell,Other
CUS028,B cell activation ,B cell activation ,BCell Activated,Other
CUS028,B cell activation ,B cell activation ,BCell Activating,Other
CUS028,B cell activation ,B cell activation ,Activation of BCell,Other
CUS028,B cell activation ,B cell activation ,BLymphocyte Activation,Other
CUS028,B cell activation ,B cell activation ,BLymphocyte Activated,Other
CUS028,B cell activation ,B cell activation ,BLymphocyte Activating,Other
CUS028,B cell activation ,B cell activation ,BCell Stimulation,Other
CUS028,B cell activation ,B cell activation ,BCell Stimulated,Other
CUS028,B cell activation ,B cell activation ,BCell Stimulating,Other
CUS028,B cell activation ,B cell activation ,Stimulation of BCell,Other
CUS028,B cell activation ,B cell activation ,BCell Triggering,Other
CUS028,B cell activation ,B cell activation ,BCell Triggered,Other
CUS028,B cell activation ,B cell activation ,Trigerring of BCell,Other
CUS029,B cell targeting ,B cell targeting ,B-Cell Targeting,Other
CUS029,B cell targeting ,B cell targeting ,B Lymphocyte Targeting,Other
CUS029,B cell targeting ,B cell targeting ,B-Lymphocyte Targeting,Other
CUS029,B cell targeting ,B cell targeting ,Targeting of B Cell,Other
CUS029,B cell targeting ,B cell targeting ,Targeting of B-Cell,Other
CUS029,B cell targeting ,B cell targeting ,Targeting of B Lymphocyte,Other
CUS029,B cell targeting ,B cell targeting ,Targeting of B-Lymphocyte,Other
CUS029,B cell targeting ,B cell targeting ,BCell Targeting,Other
CUS029,B cell targeting ,B cell targeting ,BLymphocyte Targeting,Other
CUS029,B cell targeting ,B cell targeting ,Targeting of BCell,Other
CUS029,B cell targeting ,B cell targeting ,Targeting of BLymphocyte,Other
CUS030,Complement proteins,Complement proteins,Complement-proteins,Other
CUS030,Complement proteins,Complement proteins,Complement Protein,Other
CUS030,Complement proteins,Complement proteins,Complement-Protein,Other
CUS030,Complement proteins,Complement proteins,Complementary Proteins,Other
CUS030,Complement proteins,Complement proteins,Complementary-Proteins,Other
CUS030,Complement proteins,Complement proteins,Complementary Protein,Other
CUS030,Complement proteins,Complement proteins,Complementary-Protein,Other
CUS030,Complement proteins,Complement proteins,Comp Proteins,Other
CUS030,Complement proteins,Complement proteins,Comp Protein,Other
CUS031,Complement Inhibition,Complement Inhibition,Inhibition of Complement System ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement System Inhibition ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Inhibition of Complement-System ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement-System Inhibition ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Inhibition of Complement Cascade ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement Cascade Inhibition ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Inhibition of Complement-Cascade ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement-Cascade Inhibition ,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement Pathway Inhibition,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement-Pathway Inhibition,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Inhibition of Complement Pathway,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Inhibition of Complement-Pathway,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement Inhibitor,Treatment Class
CUS031,Complement Inhibition,Complement Inhibition,Complement Inhibitors,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement System Inhibitor,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement-System Inhibitor,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement-System Inhibitors,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Inhibitors of Complement-System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Inhibitor of Complement-System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Inhibitor of Complement System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Inhibitors of Complement System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement System Blocker,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement-System Blocker,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement-System Blockers,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Blockers of Complement-System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Blocker of Complement-System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Blocker of Complement System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Blockers of Complement System,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement System Antagonist,Treatment Class
CUS032,Complement System inhibitors,Complement System inhibitors,Complement System Antagonists,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Optimised Supportive Care,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Optimal Palliative Care,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Enhanced Supportive Care,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Optimal Supportive Care,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Optimized Patient Care,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,oSoC,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Optimized Palliative care,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Tailored Supportive Treatment,Treatment Class
CUS033,optimized supportive care,Optimized Supportive Care,Tailored Supportive Care,Treatment Class
CUS034,Systemic Steroid,Systemic Steroid,Systemic Steroids ,Treatment Class
CUS034,Systemic Steroid,Systemic Steroid,Systemic Steroid,Treatment Class
CUS034,Systemic Steroid,Systemic Steroid,Systemic-Steroid,Treatment Class
CUS034,Systemic Steroid,Systemic Steroid,Systemic-Steroids,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Systemic-Glucocorticoid,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Systemic-Glucocorticoids,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Systemic Glucocorticoids,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Systemic Glucocorticoid,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Prednisone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Prednisolone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Methylprednisolone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Hydrocortisone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Dexamethasone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Betamethasone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Triamcinolone,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Deflazacort,Treatment Class
CUS035,Systemic Glucocorticoid,Systemic Glucocorticoid,Fludrocortisone,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Systemic Corticosteroid,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Systemic Corticosteroids,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Systemic-Corticosteroids,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Systemic-Corticosteroid,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Cortisone acetate,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Hydrocortisone,Treatment Class
CUS036,Systemic Corticosteroid,Systemic Corticosteroid,Fludrocortisone,Treatment Class